Erik Sims
Corporate Officer/Principal en OCUPHIRE PHARMA, INC. .
Perfil
Erik Sims is currently working as the Senior Director-Finance at Ocuphire Pharma, Inc. He previously worked as the Assistant Controller at Gemphire Therapeutics, Inc. Mr. Sims holds an MBA from Walsh College and an undergraduate degree from the University of Michigan-Flint.
Cargos activos de Erik Sims
| Empresas | Cargo | Inicio |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Corporate Officer/Principal | 01/06/2023 |
Antiguos cargos conocidos de Erik Sims.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Erik Sims.
| Walsh College | Masters Business Admin |
| University of Michigan-Flint | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Bolsa de valores
- Insiders
- Erik Sims